表紙
市場調查報告書

動物醫藥的全球市場 - 機會分析、產業預測 (2020-2027年):各產品、給藥途徑、動物種類、流通管道

Veterinary Medicine Market by Product, Route of Administration, Animal Type, and Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版商 Allied Market Research 商品編碼 955580
出版日期 內容資訊 英文 307 Pages
商品交期: 2-3個工作天內
價格
動物醫藥的全球市場 - 機會分析、產業預測 (2020-2027年):各產品、給藥途徑、動物種類、流通管道 Veterinary Medicine Market by Product, Route of Administration, Animal Type, and Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2020-2027
出版日期: 2020年07月01日內容資訊: 英文 307 Pages
簡介

動物醫藥的市場規模,到2019年達229億7300萬美金,預計至2027年達296億9800萬美元,從2020年到2027年,預計以4.6%的年複合成長率擴大。推動動物醫藥市場成長的主要原因,包含擁有寵物者數的增加與全球家畜的劇增。再加上動物的各種病情的擴大和家畜產品的需求增加等要素,也推動動物醫藥市場成長。加上,動物的醫療保健費的上升,成為推動市場成長的主要原因之一。可是,由於新興各國的動物醫藥基礎設施設備的缺乏,及藥用飼料添加物相關的嚴格法規,動物醫藥市場成長受到限制。另一方面,針對動物健康的意識高漲,提供動物醫藥市場有利機會。

本報告提供全球動物醫藥市場相關調查,市場概要與動態,各市場區隔、各地區的市場規模的分析與預測,並提供主要企業簡介等資訊。

目錄

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要企業的地位
    • 主要的投資口袋
  • 動物醫藥產業/市場形成的主要力
  • 市場動態
    • 促進因素
      • 寵物擁有的劇增
      • 全球的家畜數的增加
      • 動物醫療保健費的增加
      • 動物的各種疾病的盛行率劇增
    • 阻礙因素
      • 動物用醫藥品及疫苗相關的嚴格法規核准
      • 新興各國的動物醫藥基礎設施設備的缺乏
    • 市場機會
      • 動物的醫療保健相關意識的高漲
    • 影響分析
  • Covid-19對全球動物醫藥市場的影響分析

第4章 動物醫藥市場:各產品

  • 概要
    • 市場規模、預測
  • 藥物
    • 主要的市場趨勢、成長要素、機會
    • 市場規模、預測:各類型
      • 抗感染藥
      • 抗發炎藥
      • 殺蟲劑
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 疫苗
    • 主要的市場趨勢、成長要素、機會
    • 市場規模、預測:各類型
      • 不活化疫苗
      • 弱毒化疫苗
      • 重組疫苗
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 藥用飼料添加物
    • 主要的市場趨勢、成長要素、機會
    • 市場規模、預測:各類型
      • 氨基酸
      • 抗生素
    • 市場規模、預測:各地區
    • 市場分析:各國

第5章 動物醫藥市場:各給藥途徑

  • 概要
    • 市場規模、預測
  • 口服途徑
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 非口服途徑
  • 局部途徑

第6章 動物醫藥市場:各動物種類

  • 概要
    • 市場規模、預測
  • 寵物
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 家畜

第7章 動物醫藥市場:各銷售管道

  • 概要
    • 市場規模、預測
  • 獸醫醫院藥局
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 動物用零售藥局

第8章 動物醫藥市場:各地區

  • 概要
    • 市場規模、預測
  • 北美
    • 主要的市場趨勢、機會
    • 市場分析:各國
      • 美國
      • 加拿大
      • 墨西哥
    • 北美的市場規模、預測:各產品
    • 北美的市場規模、預測:各給藥途徑
    • 北美的市場規模、預測:各動物種類
    • 北美的市場規模、預測:各流通管道
  • 歐洲
    • 主要的市場趨勢、機會
    • 市場分析:各國
      • 德國
      • 法國
      • 英國
      • 義大利
      • 西班牙
      • 其他歐洲
    • 歐洲的市場規模、預測:各產品
    • 歐洲的市場規模、預測:各給藥途徑
    • 歐洲的市場規模、預測:各動物種類
    • 歐洲的市場規模、預測:各流通管道
  • 亞太地區
    • 主要的市場趨勢、機會
    • 市場分析:各國
      • 日本
      • 中國
      • 澳洲
      • 印度
      • 韓國
      • 其他亞太地區
    • 亞太地區的市場規模、預測:各產品
    • 亞太地區的市場規模、預測:各給藥途徑
    • 亞太地區的市場規模、預測:各動物種類
    • 亞太地區的市場規模、預測:各銷售管道
  • 南美、中東、非洲
    • 主要的市場趨勢、機會
    • 市場分析:各國
      • 巴西
      • 沙烏地阿拉伯
      • 南非
      • 其他LAMEA
    • LAMEA的市場規模、預測:各產品
    • LAMEA的市場規模、預測:各給藥途徑
    • LAMEA的市場規模、預測:各動物種類
    • LAMEA的市場規模、預測:各流通管道

第9章 企業簡介

  • Archer Daniels Midland
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC.
  • Elanco Animal Health Incorporated.
  • Evonik Industries AG (RAG Stiftung)
  • Merck & Co., Inc.
  • Soparfin SCA.
  • Virbac SA.
  • Zoetis Inc.
目錄
Product Code: A03026

Title:
Veterinary Medicine Market by Product (Drugs, Vaccines, and Medicated Feed Additives), Route of Administration (Oral Route, Parenteral Route, and Topical Route), Animal Type (Companion Animals and Livestock Animals), and Distribution Channel (Veterinary Hospitals Pharmacies, and Retail Veterinary Pharmacies): Global Opportunity Analysis and Industry Forecast, 2020-2027.

The veterinary medicine market accounted for $22,973 million in 2019, and is expected to reach $29,698 million by 2027, registering a CAGR of 4.6% from 2020 to 2027.

Veterinary medicine is defined as a drug or other preparations employed in the treatment of animals. Furthermore, other preparations such as vaccines and medicated feed additives are also used to treat various medical conditions in animals. In addition, these medicines include different type of products such as anti-infective drugs, which are used to prevent, kill, or slow the growth of bacteria, fungi and other infection causing organisms. These medicines also include anti-inflammatory drugs, which are routinely used for relief of pain and inflammation associated with osteoarthritis, and other medical conditions in livestock and companion animals. Furthermore, parasiticide is another type of veterinary drug, which are employed in prevention or elimination of external and internal parasites such as fleas, ticks, and worms. Other than drugs, vaccines are also used in treatment of various medical conditions in animals. Some types of veterinary vaccines include inactivated vaccines, attenuated vaccines, and recombinant vaccine.

Similarly, medicated feed additives are also used to cure medical conditions in livestock and companion animals. In addition, these different types of drugs are administered to animals through different routes such as oral, parenteral and topical. Furthermore, these drugs are used in treatment of companion animals such as dogs, cats and horses and are also used in treatment of livestock animals such as pigs, dairy cattle, beef cattle, and poultry.

The major factors that contribute toward the growth of the veterinary medicine market include rise in number of pet owners and surge in livestock population across the globe. Furthermore, factors such as surge in prevalence of various medical conditions in animals and rise in demand for livestock products also boost growth of the veterinary medicine market. In addition, rise in animal healthcare expenditure is another major factor that fuels growth of the market. However, lack of veterinary infrastructure facilities in underdeveloped nations and stringent regulations associated with medicate feed additives restrict growth of the veterinary medicine market. Conversely, increase in awareness toward animal health offers a lucrative opportunity for the veterinary medicine market.

The global veterinary medicine market is segmented on the basis of product, route of administration, animal type, distribution channel, and region to provide a detailed assessment of the market. By product, the market is divided into drugs, vaccines, and medicated feed additives. The drugs segment is further divided into anti-infective, anti-inflammatory, and parasiticide. In addition, the vaccines segment is divided into inactivated vaccines, attenuated vaccines, and recombinant vaccines. Similarly, the medicated feed additives segment is divided into amino acids and antibiotics. By route of administration, the market is classified into oral route, parenteral route, and topical route. By animal type, it is divided into companion animals and livestock animals. By distribution channel, it is classified into veterinary hospitals, veterinary clinics, and pharmacies & drug stores. By region, the veterinary medicine market size is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The major players in the veterinary medicine market are Zoetis, Inc., Merck & Co., Inc. (Intervet International B.V.), Elanco Animal Health, Dechra Pharmaceuticals PLC, Ceva Sante Animale, Virbac., Vetoquinol S.A., Boehringer Ingelheim International GmbH., ADM Animal Nutrition, and Evonik Industries AG.

KEY BENEFITS FOR STAKEHOLDERS

This report entails a detailed quantitative analysis along with the current global negative pressure wound therapy devices market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessments.

The market size and estimations are based on a comprehensive analysis of key developments in the industry.

A qualitative analysis based on innovative products facilitates strategic business planning.

The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments

By Product

Drugs

Anti-infective

Anti-inflammatory

Parasiticide

Vaccines

Inactivated Vaccines

Attenuated Vaccines

Recombinant Vaccines

Medicated Feed Additives

Amino Acids

Antibiotics

By Route of Administration

Oral Route

Parenteral Route

Topical Route

By Route of Administration

Oral Route

Parenteral Route

Topical Route

By Animal Type

Companion Animals

Livestock Animals

By Distribution Channel

Veterinary Hospital Pharmacies

Retail Veterinary Pharmacies

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

South Korea

Rest of Asia-Pacific

LAMEA

Brazil

Saudi Arabia

South Africa

Rest of LAMEA

List of key players profiled in the report:

  • Zoetis, Inc.
  • Merck & Co., Inc. (Intervet International B.V.)
  • Elanco Animal Health
  • Dechra Pharmaceuticals PLC
  • Ceva Sante Animale
  • Virbac.
  • Vetoquinol S.A.
  • Boehringer Ingelheim International GmbH.
  • ADM Animal Nutrition
  • Evonik Industries AG
  • LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
  • Pharmgate Inc.
  • Bimedia, Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
    • 1.2.1.List of key players profiled in the report
  • 1.3.Research methodology
    • 1.3.1.Primary research
    • 1.3.2.Secondary research
    • 1.3.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Top player positioning
    • 3.2.1.Top investment pockets
  • 3.3.Key forces shaping veterinary medicines industry/market
  • 3.4.Market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1.Surge in ownership of companion animals
      • 3.4.1.2.Rise in livestock population across the globe
      • 3.4.1.3.Rise in animal healthcare expenditure
      • 3.4.1.4.Surge in prevalence of various medical conditions in animals
    • 3.4.2.Restraint
      • 3.4.2.1.Stringent regulatory approvals related to veterinary drugs and vaccines
      • 3.4.2.2.Lack of veterinary infrastructure facilities in underdeveloped nations
    • 3.4.3.Opportunity
      • 3.4.3.1.Surge in awareness related to animal healthcare
    • 3.4.4.Impact Analyses
  • 3.5.Covid-19 impact analysis on global veterinary medicine market

CHAPTER 4:VETERINARY MEDICINE MARKET, BY PRODUCT

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Drugs
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by type
      • 4.2.2.1.Anti-infective
      • 4.2.2.1.1.Market size and forecast
      • 4.2.2.2.Anti-inflammatory
      • 4.2.2.2.1.Market size and forecast
      • 4.2.2.3.Parasiticide
      • 4.2.2.3.1.Market size and forecast
    • 4.2.3.Market size and forecast, by region
    • 4.2.4.Market analysis, by country
  • 4.3.Vaccines
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast, by type
      • 4.3.2.1.Inactivated Vaccines
      • 4.3.2.1.1.Market size and forecast
      • 4.3.2.2.Attenuated Vaccines
      • 4.3.2.2.1.Market size and forecast
      • 4.3.2.3.Recombinant Vaccines
      • 4.3.2.3.1.Market size and forecast
    • 4.3.3.Market size and forecast, by region
    • 4.3.4.Market analysis, by country
  • 4.4.Medicated feed additives
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast, by type
      • 4.4.2.1.Amino Acids
      • 4.4.2.1.1.Market size and forecast
      • 4.4.2.2.Antibiotics
      • 4.4.2.2.1.Market size and forecast
    • 4.4.3.Market size and forecast, by region
    • 4.4.4.Market analysis, by country

CHAPTER 5:VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINSTRATION

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Oral route
    • 5.2.1.Market size and forecast, by region
    • 5.2.2.Market analysis by country
  • 5.3.Parenteral route
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis by country
  • 5.4.Topical route
    • 5.4.1.Market size and forecast, by region
    • 5.4.2.Market analysis by country

CHAPTER 6:VETERINARY MEDICINE MARKET, BY ANIMAL TYPE

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Companion animal
    • 6.2.1.Market size and forecast, by region
    • 6.2.2.Market analysis, by country
  • 6.3.Livestock animals
    • 6.3.1.Market size and forecast, by region
    • 6.3.2.Market analysis, by country

CHAPTER 7:VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.Veterinary hospital pharmacies
    • 7.2.1.Market size and forecast, by region
    • 7.2.2.Market analysis, by country
  • 7.3.Retail veterinary pharmacies
    • 7.3.1.Market size and forecast, by region
    • 7.3.2.Market analysis, by country

CHAPTER 8:VETERINARY MEDICINE MARKET, BY REGION

  • 8.1.Overview
    • 8.1.1.Market size and forecast
  • 8.2.North America
    • 8.2.1.Key market trends and opportunities
    • 8.2.2.Market analysis, by country
      • 8.2.2.1.U.S.
      • 8.2.2.1.1.U.S. market size and forecast, by product
      • 8.2.2.1.2.U.S. market size and forecast, by route of administration
      • 8.2.2.1.3.U.S. market size and forecast, by animal type
      • 8.2.2.1.4.U.S. market size and forecast, by distribution channel
      • 8.2.2.2.Canada
      • 8.2.2.2.1.Canada market size and forecast, by product
      • 8.2.2.2.2.Canada market size and forecast, by route of administration
      • 8.2.2.2.3.Canada market size and forecast, by animal type
      • 8.2.2.2.4.Canada market size and forecast, by distribution channel
      • 8.2.2.3.Mexico
      • 8.2.2.3.1.Mexico market size and forecast, by product
      • 8.2.2.3.2.Mexico market size and forecast, by route of administration
      • 8.2.2.3.3.Mexico market size and forecast, by animal type
      • 8.2.2.3.4.Mexico market size and forecast, by distribution channel
    • 8.2.3.North America market size and forecast, by product
    • 8.2.4.North America market size and forecast, by route of administration
    • 8.2.5.North America market size and forecast, by animal type
    • 8.2.6.North America market size and forecast, by distribution channel
  • 8.3.Europe
    • 8.3.1.Key market trends and opportunities
    • 8.3.2.Market analysis, by country
      • 8.3.2.1.Germany
      • 8.3.2.1.1.Germany market size and forecast, by product
      • 8.3.2.1.2.Germany market size and forecast, by route of administration
      • 8.3.2.1.3.Germany market size and forecast, by animal type
      • 8.3.2.1.4.Germany market size and forecast, by distribution channel
      • 8.3.2.2.France
      • 8.3.2.2.1.France market size and forecast, by product
      • 8.3.2.2.2.France market size and forecast, by route of administration
      • 8.3.2.2.3.France market size and forecast, by animal type
      • 8.3.2.2.4.France market size and forecast, by distribution channel
      • 8.3.2.3.UK
      • 8.3.2.3.1.UK market size and forecast, by product
      • 8.3.2.3.2.UK market size and forecast, by route of administration
      • 8.3.2.3.3.UK market size and forecast, by animal type
      • 8.3.2.3.4.UK market size and forecast, by distribution channel
      • 8.3.2.4.Italy
      • 8.3.2.4.1.Italy market size and forecast, by product
      • 8.3.2.4.2.Italy market size and forecast, by route of administration
      • 8.3.2.4.3.Italy market size and forecast, by animal type
      • 8.3.2.4.4.Italy market size and forecast, by distribution channel
      • 8.3.2.5.Spain
      • 8.3.2.5.1.Spain market size and forecast, by product
      • 8.3.2.5.2.Spain market size and forecast, by route of administration
      • 8.3.2.5.3.Spain market size and forecast, by animal type
      • 8.3.2.5.4.Spain market size and forecast, by distribution channel
      • 8.3.2.6.Rest of Europe
      • 8.3.2.6.1.Rest of Europe market size and forecast, by product
      • 8.3.2.6.2.Rest of Europe market size and forecast, by route of administration
      • 8.3.2.6.3.Rest of Europe market size and forecast, by animal type
      • 8.3.2.6.4.Rest of Europe market size and forecast, by distribution channel
    • 8.3.3.Europe market size and forecast, by product
    • 8.3.4.Europe market size and forecast, by route of administration
    • 8.3.5.Europe market size and forecast, by animal type
    • 8.3.6.Europe market size and forecast, by distribution channel
  • 8.4.Asia-Pacific
    • 8.4.1.Key market trends and opportunities
    • 8.4.2.Market analysis, by country
      • 8.4.2.1.Japan
      • 8.4.2.1.1.Japan market size and forecast, by product
      • 8.4.2.1.2.Japan market size and forecast, by route of administration
      • 8.4.2.1.3.Japan market size and forecast, by animal type
      • 8.4.2.1.4.Japan market size and forecast, by distribution channel
      • 8.4.2.2.China
      • 8.4.2.2.1.China market size and forecast, by product
      • 8.4.2.2.2.China market size and forecast, by route of administration
      • 8.4.2.2.3.China market size and forecast, by animal type
      • 8.4.2.2.4.China market size and forecast, by distribution channel
      • 8.4.2.3.Australia
      • 8.4.2.3.1.Australia market size and forecast, by product
      • 8.4.2.3.2.Australia market size and forecast, by route of administration
      • 8.4.2.3.3.Australia market size and forecast, by animal type
      • 8.4.2.3.4.Australia market size and forecast, by distribution channel
      • 8.4.2.4.India
      • 8.4.2.4.1.India market size and forecast, by product
      • 8.4.2.4.2.India market size and forecast, by route of administration
      • 8.4.2.4.3.India market size and forecast, by animal type
      • 8.4.2.4.4.India market size and forecast, by distribution channel
      • 8.4.2.5.South Korea
      • 8.4.2.5.1.South Korea market size and forecast, by product
      • 8.4.2.5.2.South Korea market size and forecast, by route of administration
      • 8.4.2.5.3.South Korea market size and forecast, by animal type
      • 8.4.2.5.4.South Korea market size and forecast, by distribution channel
      • 8.4.2.6.Rest of Asia-Pacific
      • 8.4.2.6.1.Rest of Asia-Pacific market size and forecast, by product
      • 8.4.2.6.2.Rest of Asia-Pacific market size and forecast, by route of administration
      • 8.4.2.6.3.Rest of Asia-Pacific market size and forecast, by animal type
      • 8.4.2.6.4.Rest of Asia-Pacific market size and forecast, by distribution channel
    • 8.4.3.Asia-Pacific market size and forecast, by product
    • 8.4.4.Asia-Pacific market size and forecast, by route of administration
    • 8.4.5.Asia-Pacific market size and forecast, by animal type
    • 8.4.6.Asia-Pacific market size and forecast, by distribution channel
  • 8.5.LAMEA
    • 8.5.1.Key market trends and opportunities
    • 8.5.2.Market analysis, by country
      • 8.5.2.1.Brazil
      • 8.5.2.1.1.Brazil market size and forecast, by product
      • 8.5.2.1.2.Brazil market size and forecast, by route of administration
      • 8.5.2.1.3.Brazil market size and forecast, by animal type
      • 8.5.2.1.4.Brazil market size and forecast, by distribution channel
      • 8.5.2.2.Saudi Arabia
      • 8.5.2.2.1.Saudi Arabia market size and forecast, by product
      • 8.5.2.2.2.Saudi Arabia market size and forecast, by route of administration
      • 8.5.2.2.3.Saudi Arabia market size and forecast, by animal type
      • 8.5.2.2.4.Saudi Arabia market size and forecast, by distribution channel
      • 8.5.2.3.South Africa
      • 8.5.2.3.1.South Africa market size and forecast, by product
      • 8.5.2.3.2.South Africa market size and forecast, by route of administration
      • 8.5.2.3.3.South Africa market size and forecast, by animal type
      • 8.5.2.3.4.South Africa market size and forecast, by distribution channel
      • 8.5.2.4.Rest of LAMEA
      • 8.5.2.4.1.Rest of LAMEA market size and forecast, by product
      • 8.5.2.4.2.Rest of LAMEA market size and forecast, by route of administration
      • 8.5.2.4.3.Rest of LAMEA market size and forecast, by animal type
      • 8.5.2.4.4.Rest of LAMEA market size and forecast, by distribution channel
    • 8.5.3.LAMEA market size and forecast, by product
    • 8.5.4.LAMEA market size and forecast, by route of administration
    • 8.5.5.LAMEA market size and forecast, by animal type
    • 8.5.6.LAMEA market size and forecast, by distribution channel

CHAPTER 9:COMPANY PROFILES

  • 9.1.Archer Daniels Midland
    • 9.1.1.Company overview
    • 9.1.2.Company snapshot
    • 9.1.3.Operating business segments
    • 9.1.4.Product portfolio
    • 9.1.5.Business performance
  • 9.2.Boehringer Ingelheim International GmbH
    • 9.2.1.Company overview
    • 9.2.2.Company snapshot
    • 9.2.3.Operating business segments
    • 9.2.4.Product portfolio
    • 9.2.5.Business performance
  • 9.3.Ceva Sante Animale
    • 9.3.1.Company overview
    • 9.3.2.Company snapshot
    • 9.3.3.Operating business segments
    • 9.3.4.Product portfolio
  • 9.4.Dechra Pharmaceuticals PLC.
    • 9.4.1.Company overview
    • 9.4.2.Company snapshot
    • 9.4.3.Operating business segments
    • 9.4.4.Product portfolio
    • 9.4.5.Business performance
  • 9.5.Elanco Animal Health Incorporated.
    • 9.5.1.Company overview
    • 9.5.2.Company snapshot
    • 9.5.3.Operating business segments
    • 9.5.4.Product portfolio
    • 9.5.5.Business performance.
    • 9.5.6.Key strategic moves and developments
  • 9.6.Evonik Industries AG (RAG Stiftung)
    • 9.6.1.Company overview
    • 9.6.2.Company snapshot
    • 9.6.3.Operating business segments
    • 9.6.4.Product portfolio
    • 9.6.5.Business performance
    • 9.6.6.Key strategic moves and developments
  • 9.7.Merck & Co., Inc.
    • 9.7.1.Company overview
    • 9.7.2.Company snapshot
    • 9.7.3.Operating business segments
    • 9.7.4.Product portfolio
    • 9.7.5.Business performance
    • 9.7.6.Key strategic moves and developments
  • 9.8.Soparfin SCA.
    • 9.8.1.Company overview
    • 9.8.2.Company snapshot
    • 9.8.3.Operating business segments
    • 9.8.4.Product portfolio
    • 9.8.5.Key strategic moves and developments
  • 9.9.Virbac SA.
    • 9.9.1.Company overview
    • 9.9.2.Company snapshot
    • 9.9.3.Operating business segments
    • 9.9.4.Product portfolio
    • 9.9.5.Business performance
    • 9.9.6.Key strategic moves and developments
  • 9.10.Zoetis Inc.
    • 9.10.1.Company overview
    • 9.10.2.Company snapshot
    • 9.10.3.Operating business segments
    • 9.10.4.Product portfolio
    • 9.10.5.Business performance
    • 9.10.6.Key strategic moves and developments

LIST OF TABLES

  • TABLE 01.NUMBER OF U.S. HOUSEHOLDS THAT OWN A PET, BY TYPE OF ANIMAL (MILLIONS)
  • TABLE 02.POPULATION OF CATS AND DOGS IN EUROPEAN COUNTRIES, 2018
  • TABLE 03.MAJOR SPECIES OF LIVESTOCK POPULATION IN INDIA, 2012 & 2019 (IN MILLION)
  • TABLE 04.PARASITE DISEASES & THEIR PREVALENCE IN U.S., 2019
  • TABLE 05.VETERINARY MEDICINE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 06.VETERINARY MEDICINE MARKET FOR DRUGS, BY TYPE, 2019-2027($MILLION)
  • TABLE 07.ANTI-INFECTIVE MARKET, 2019-2027 ($MILLION)
  • TABLE 08.ANTI-INFLAMMATORY MARKET, 2019-2027 ($MILLION)
  • TABLE 09.PARASITICIDE MARKET, 2019-2027 ($MILLION)
  • TABLE 10.VETERINARY MEDICINE MARKET FOR DRUGS, BY REGION 2019-2027($MILLION)
  • TABLE 11.VETERINARY MEDICINE MARKET FOR VACCINES, BY TYPE 2019-2027($MILLION)
  • TABLE 12.INACTIVATED VACCINES MARKET, 2019-2027 ($MILLION)
  • TABLE 13.ATTENUATED VACCINES MARKET, 2019-2027 ($MILLION)
  • TABLE 14.RECOMBINANT VACCINES MARKET, 2019-2027 ($MILLION)
  • TABLE 15.VETERINARY MEDICINE MARKET FOR VACCINES, BY REGION 2019-2027($MILLION)
  • TABLE 16.VETERINARY MEDICINE MARKET FOR MEDICATED FEED ADDITIVES, BY TYPE 2019-2027($MILLION)
  • TABLE 17.AMINO ACIDS MARKET, 2019-2027 ($MILLION)
  • TABLE 18.ANTIBIOTICS MARKET, 2019-2027 ($MILLION)
  • TABLE 19.VETERINARY MEDICINE MARKET FOR MEDICATED FEED ADDITIVES, BY REGION 2019-2027($MILLION)
  • TABLE 20.VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($MILLION)
  • TABLE 21.VETERINARY MEDICINE MARKET FOR ORAL ROUTE, BY REGION 2019-2027C($MILLION)
  • TABLE 22.VETERINARY MEDICINE MARKET FOR PARENTERAL ROUTE, BY REGION 2019-2027 ($MILLION)
  • TABLE 23.VETERINARY MEDICINE MARKET FOR TOPICAL ROUTE, BY REGION 2019-2027 ($MILLION)
  • TABLE 24.VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2019-2027 ($MILLION)
  • TABLE 25.VETERINARY MEDICINE MARKET FOR COMPANION ANIMALS, BY REGION 2019-2027($MILLION)
  • TABLE 26.VETERINARY MEDICINE MARKET FOR LIVESTOCK ANIMALS, BY REGION 2019-2027 ($MILLION)
  • TABLE 27.VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 ($MILLION)
  • TABLE 28.VETERINARY MEDICINE MARKET FOR VETERINARY HOSPITAL PHARMACIES, BY REGION 2019-2027($MILLION)
  • TABLE 29.VETERINARY MEDICINE MARKET FOR RETAIL VETERINARY PHARMACIES, BY REGION 2019-2027 ($MILLION)
  • TABLE 30.VETERINARY MEDICINE MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 31.NORTH AMERICA VETERINARY MEDICINE MARKET REVENUE, BY COUNTRY, 2020-2027 ($MILLION)
  • TABLE 32.U.S. VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 33.U.S. VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 34.U.S. VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 35.U.S. VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 36.CANADA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 37.CANADA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 38.CANADA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 39.CANADA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 40.MEXICO VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 41.MEXICO VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 42.MEXICO VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 43.MEXICO VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 44.NORTH AMERICA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027($MILLION)
  • TABLE 45.NORTH AMERICA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027($MILLION)
  • TABLE 46.NORTH AMERICA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027($MILLION)
  • TABLE 47.NORTH AMERICA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027($MILLION)
  • TABLE 48.EUROPE VETERINARY MEDICINE MARKET REVENUE, BY COUNTRY, 2020-2027 ($MILLION)
  • TABLE 49.GERMANY VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 50.GERMANY VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 51.GERMANY VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 52.GERMANY VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 53.FRANCE VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 54.FRANCE VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 55.FRANCE VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 56.FRANCE VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 57.UK VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 58.UK VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 59.UK VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 60.UK VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 61.ITALY VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 62.ITALY VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 63.ITALY VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 64.ITALY VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 65.SPAIN VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 66.SPAIN VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 67.SPAIN VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 68.SPAIN VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 69.REST OF EUROPE VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 70.REST OF EUROPE VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 71.REST OF EUROPE VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 72.REST OF EUROPE VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 73.EUROPE VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027($MILLION)
  • TABLE 74.EUROPE VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027($MILLION)
  • TABLE 75.EUROPE VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027($MILLION)
  • TABLE 76.EUROPE VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027($MILLION)
  • TABLE 77.ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY COUNTRY, 2020-2027 ($MILLION)
  • TABLE 78.JAPAN VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 79.JAPAN VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 80.JAPAN VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 81.JAPAN VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 82.CHINA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 83.CHINA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 84.CHINA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 85.CHINA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 86.AUSTRALIA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 87.AUSTRALIA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 88.AUSTRALIA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 89.AUSTRALIA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 90.INDIA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 91.INDIA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 92.INDIA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 93.INDIA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 94.SOUTH KOREA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 95.SOUTH KOREA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 96.SOUTH KOREA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 97.SOUTH KOREA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 98.REST OF ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 99.REST OF ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 100.REST OF ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 101.REST OF ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 102.ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027($MILLION)
  • TABLE 103.ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027($MILLION)
  • TABLE 104.ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027($MILLION)
  • TABLE 105.ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027($MILLION)
  • TABLE 106.LAMEA VETERINARY MEDICINE MARKET REVENUE, BY COUNTRY, 2020-2027 ($MILLION)
  • TABLE 107.BRAZIL VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 108.BRAZIL VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 109.BRAZIL VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 110.BRAZIL VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 111.SAUDI ARABIA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 112.SAUDI ARABIA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 113.SAUDI ARABIA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 114.SAUDI ARABIA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 115.SOUTH AFRICA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 116.SOUTH AFRICA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 117.SOUTH AFRICA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 118.SOUTH AFRICA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 119.REST OF LAMEA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027 ($MILLION)
  • TABLE 120.REST OF LAMEA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027 ($MILLION)
  • TABLE 121.REST OF LAMEA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020-2027 ($MILLION)
  • TABLE 122.REST OF LAMEA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027 ($MILLION)
  • TABLE 123.LAMEA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020-2027($MILLION)
  • TABLE 124.LAMEA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027($MILLION)
  • TABLE 125.LAMEA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020-2027($MILLION)
  • TABLE 126.LAMEA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020-2027($MILLION)
  • TABLE 127.ADM: COMPANY SNAPSHOT
  • TABLE 128.ADM: OERATING SEGMENT
  • TABLE 129.ADM: PRODUCT PORTFOLIO
  • TABLE 130.BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
  • TABLE 131.BOEHRINGER INGELHEIM: PRODUCT BUSINESS SEGMENTS
  • TABLE 132.BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
  • TABLE 133.CEVA: COMPANY SNAPSHOT
  • TABLE 134.CEVA: OPERATING SEGMENTS
  • TABLE 135.CEVA: PRODUCT PORTFOLIO
  • TABLE 136.DECHRA: COMPANY SNAPSHOT
  • TABLE 137.DECHRA: OPERATING BUSINESS SEGMENTS
  • TABLE 138.DECHRA: PRODUCT PORTFOLIO
  • TABLE 139.ELANCO: COMPANY SNAPSHOT
  • TABLE 140.ELANCO: OPERATING SEGMENTS
  • TABLE 141.ELANCO: PRODUCT PORTFOLIO
  • TABLE 142.EVONIK: COMPANY SNAPSHOT
  • TABLE 143.EVONIK: OPERATING SEGMENTS
  • TABLE 144.EVONIK: PRODUCT PORTFOLIO
  • TABLE 145.MERCK.: COMPANY SNAPSHOT
  • TABLE 146.MERCK.: OPERATING SEGMENTS
  • TABLE 147.MERCK.: PRODUCT PORTFOLIO
  • TABLE 148.SOPARFIN: COMPANY SNAPSHOT
  • TABLE 149.SOPARFIN: PRODUCT SEGMENTS
  • TABLE 150.SOPARFIN: PRODUCT PORTFOLIO
  • TABLE 151.VIRBAC: COMPANY SNAPSHOT
  • TABLE 152.VIRBAC: OPERATING BUSINESS SEGMENTS
  • TABLE 153.VIRBAC: PRODUCT PORTFOLIO
  • TABLE 154.ZOETIS: COMPANY SNAPSHOT
  • TABLE 155.ZOETIS: OPERATING BUSINESS SEGMENTS
  • TABLE 156.ZOETIS: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.GLOBAL VETERINARY MEDICINE MARKET SEGMENTATION
  • FIGURE 02.TOP PLAYER POSITIONING, 2019
  • FIGURE 03.TOP INVESTMENT POCKETS
  • FIGURE 04.HIGH BARGAINING POWER OF SUPPLIER
  • FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06.HIGH THREAT OF SUBSTITUTES
  • FIGURE 07.MODERATE INTENSITY OF RIVALRY
  • FIGURE 08.LOW THREAT OF NEW ENTRANT
  • FIGURE 09.IMPACT ANALYSES, VETERINARY MEDICINE MARKET
  • FIGURE 10.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR DRUGS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 11.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR VACCINES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 12.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR MEDICATED FEED ADDITIVES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR ORAL ROUTE, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR PARENTERAL ROUTE, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR TOPICAL ROUTE, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR VETERINARY HOSPITAL PHARMACIES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR RETAIL VETERIANRY PHARMACIES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 20.U.S. VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 21.CANADA VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 22.MEXICO VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 23.GERMANY VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 24.FRANCE VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 25.UK VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 26.ITALY VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 27.SPAIN VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 28.REST OF EUROPE VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 29.JAPAN VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 30.CHINA VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 31.AUSTRALIA VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 32.INDIA VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 33.SOUTH KOREA VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 34.REST OF ASIA-PACIFIC VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 35.BRAZIL VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 36.SAUDI ARABIA VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 37.SOUTH AFRICA VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 38.REST OF LAMEA VETERINARY MEDICINE MARKET, 2020-2027 ($MILLION)
  • FIGURE 39.ADM: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 40.ADM: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 41.ADM: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 42.BOEHRINGER INGELHEIM: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 43.BOEHRINGER INGELHEIM: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 44.BOEHRINGER INGELHEIM: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 45.DECHRA: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 46.DECHRA: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 47.DECHRA: REVENUE SHARE, BY REGION, 2019(%)
  • FIGURE 48.ELANCO: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 49.ELANCO: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 50.ELANCO: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 51.EVONIK: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 52.EVONIK: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 53.MERCK.: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 54.MERCK: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 55.MERCK: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 56.VIRBAC: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 57.VIRBAC: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 58.VIRBAC: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 59.ZOETIS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 60.ZOETIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 61.ZOETIS: REVENUE SHARE, BY REGION, 2019 (%)